Lily Mulugeta is an Associate Director for Policy and Research in the Division of Pediatrics at the FDA. She engages in scientific and regulatory review and research related to pediatric drug development. Dr. Mulugeta serves as a representative for the Division on the FDA Pediatric Review Committee (PeRC). Prior to joining the Division in 2017, Lily was the Scientific Lead for Pediatrics in the Division of Pharmacometrics at the FDA. Prior to joining the FDA, Dr. Mulugeta practiced as a Critical Care Specialist at Children’s National Medical Center in Washington D.C. She also served as a faculty member in the Department of Pediatrics at the George Washington School of Medicine and in the Department of Pharmacy at the University of Maryland College of Pharmacy School of Pharmacy. Dr. Mulugeta received her Pharm.D. degree from the University of Kentucky College of Pharmacy and completed a pediatric residency at Inova Fairfax Hospital in Falls Church, Virginia.